Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Dec 8, 2017
Targets & Mechanisms

Pathways emerging from ASH

An analysis of emerging targets at ASH by mechanism
BioCentury | Aug 31, 2017
Translation in Brief

Mouse model herds

International Mouse Phenotyping Consortium publishes data on 185 disease models
BioCentury | Dec 7, 2015
Clinical News

Amatuximab: Phase II started

BioCentury | Feb 10, 2014
Clinical News

Amatuximab regulatory update

BioCentury | May 28, 2012
Clinical News

Amatuximab: Interim Phase II data

Items per page:
1 - 5 of 5